Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $6,854 | 18 | 68.4% |
| Food and Beverage | $3,169 | 89 | 31.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,030 | 12 | $0 (2024) |
| Pulmonx Corporation | $1,422 | 7 | $0 (2023) |
| Medical Device Business Services, Inc. | $1,272 | 6 | $0 (2022) |
| Pinnacle Biologics, Inc | $1,240 | 9 | $0 (2020) |
| Ethicon Inc. | $1,124 | 7 | $0 (2024) |
| Auris Health, Inc. | $768.00 | 3 | $0 (2018) |
| Spiration, Inc. | $677.28 | 3 | $0 (2017) |
| GlaxoSmithKline, LLC. | $501.03 | 15 | $0 (2024) |
| Philips Electronics North America Corporation | $263.58 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $166.85 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $791.36 | 32 | GlaxoSmithKline, LLC. ($219.84) |
| 2023 | $1,208 | 20 | Boston Scientific Corporation ($699.46) |
| 2022 | $1,782 | 23 | Medical Device Business Services, Inc. ($1,272) |
| 2020 | $1,292 | 11 | Pinnacle Biologics, Inc ($1,240) |
| 2019 | $3,481 | 13 | Boston Scientific Corporation ($1,253) |
| 2018 | $779.40 | 4 | Auris Health, Inc. ($768.00) |
| 2017 | $690.48 | 4 | Spiration, Inc. ($677.28) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Neurology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Pulmonology | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.53 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/07/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Endo-Mechanical | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Respiratory | ||||||
| 05/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/13/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 04/10/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $46.71 | General |
| Category: Airway Clearance Device | ||||||
| 03/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 799 | 1,141 | $240,554 | $102,808 |
| 2022 | 19 | 823 | 1,111 | $230,466 | $102,320 |
| 2021 | 19 | 853 | 1,072 | $228,638 | $97,676 |
| 2020 | 17 | 999 | 1,602 | $403,249 | $181,442 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 96 | 256 | $113,237 | $43,112 | 38.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 82 | 140 | $20,732 | $13,666 | 65.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 182 | $18,819 | $11,810 | 62.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 76 | $21,660 | $10,212 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 57 | $8,607 | $5,231 | 60.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 47 | $4,794 | $3,370 | 70.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,389 | $2,623 | 59.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 17 | $3,451 | $2,163 | 62.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 43 | 52 | $2,860 | $2,144 | 74.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 48 | 48 | $4,272 | $1,296 | 30.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 48 | 48 | $4,800 | $1,281 | 26.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,112 | $1,117 | 52.9% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 14 | 14 | $5,208 | $1,074 | 20.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 48 | 48 | $5,721 | $940.70 | 16.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 39 | 40 | $3,160 | $870.75 | 27.6% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 14 | 14 | $3,490 | $767.76 | 22.0% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 12 | 13 | $3,994 | $459.17 | 11.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 17 | 17 | $4,933 | $342.76 | 6.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 14 | 14 | $1,400 | $125.97 | 9.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 14 | 14 | $1,669 | $108.16 | 6.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 14 | 14 | $1,246 | $94.12 | 7.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 80 | 215 | $96,223 | $38,669 | 40.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 77 | 82 | $23,370 | $13,259 | 56.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 85 | 116 | $17,332 | $9,748 | 56.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 81 | 156 | $16,004 | $9,092 | 56.8% |
About Dr. Philip Kaplan, DO
Dr. Philip Kaplan, DO is a Critical Care Medicine healthcare provider based in Novi, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295734044.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Kaplan, DO has received a total of $10,023 in payments from pharmaceutical and medical device companies, with $791.36 received in 2024. These payments were reported across 107 transactions from 24 companies. The most common payment nature is "Travel and Lodging" ($6,854).
As a Medicare-enrolled provider, Kaplan has provided services to 3,474 Medicare beneficiaries, totaling 4,926 services with total Medicare billing of $484,246. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Novi, MI
- Active Since 07/14/2005
- Last Updated 05/15/2009
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1295734044
Products in Payments
- Photofrin (Drug) $1,240
- Pulmonx Endobronchial Valve EBV (Device) $1,191
- MONARCH (Device) $1,077
- GENERAL PULMONARY (Device) $1,033
- Spiration Valve System (Device) $677.28
- (7999) SRC Und (Device) $263.58
- AREXVY (Drug) $242.94
- ULTRAFLEX (Device) $220.27
- ZEPHYR DELIVERY CATHETER (Device) $134.51
- DUPIXENT (Biological) $119.08
- TRELEGY ELLIPTA (Drug) $117.13
- Prolastin-C Liquid (Biological) $99.21
- AIRSUPRA (Drug) $98.01
- CHARTIS CATHETER (Device) $96.83
- GLASSIA (Biological) $50.49
- Monarch Platform (Device) $47.04
- Hillrom - Vest System Model 105 Home Care (Device) $46.71
- TYVASO (Drug) $46.53
- OFEV (Drug) $45.19
- Yupelri (Drug) $29.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Novi
Mrs. Lauren West, Msn, Np-C, MSN, NP-C
Critical Care Medicine — Payments: $291.40
Michael Dunn, M.d, M.D
Critical Care Medicine — Payments: $33.04
Abigail Fox
Critical Care Medicine
Christina Oakley
Critical Care Medicine